FOI release

Freedom of Information responses from the MHRA - week commencing 18 April 2022

The Medicines and Healthcare products Regulatory Agency (MHRA) responses to freedom of information (FOI) requests for week commencing 18 April 2022

• From: Medicines and Healthcare products Regulatory Agency
• Published: 14 June 2022

Documents

Freedom of Information request on the yellow card reports following testosterone treatment (FOI 22/580)

HTML

FOI-22-580-1

PDF, 18.6 KB, 2 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Freedom of Information request on the risk management plan for Betamethasone sodium phosphate 500mcg soluble tablets (FOI 22/585)

HTML

FOI-22-585-1

PDF, 360 KB, 22 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The Medicines and Healthcare products Regulatory Agency (MHRA) responses to freedom of information (FOI) requests for week commencing 18 April 2022

Published 14 June 2022